Propofol (techno drugs ltd)

Faruk Hossain
Faruk HossainSr. Executive-Global Business @ Beacon Medicare Limited. à Beacon Medicare Limited
Techno Drugs Ltd.
Welcome to the training program
Short –acting IV anesthetic
agent.
Propofol
Propofol BP
Product Profile:
• Brand Name: Propofol
• Generic Name: Propofol
• Therapeutic Class : Anesthesia
• Strength : 20 ml IV injection (10 mg/ml )
Description:
• Propofol® Injectable Emulsion is a sterile, non
pyrogenic emulsion containing 10 mg/ml of
propofol suitable for intravenous administration.
Propofol is slightly soluble in water and, thus, is
formulated in a white to light yellow, oil-in-water
emulsion. In addition to the active component,
Propofol®, the formulation also contains soybean
oil (100 mg/ml), glycerol (22.5 mg/ml), egg
lecithin (12 mg/ml) and disodium edetate (0.005%)
with sodium hydroxide to adjust pH.
Pharmacology:
Propofol® Injectable Emulsion is an IV sedative-
hypnotic agent for use in the induction and
maintenance of anesthesia or sedation.
IV injection of a therapeutic dose of propofol
induces hypnosis, with minimal excitation, usually
within 40 seconds from the start of injection (the
time for one arm-brain circulation). As with other
rapidly acting IV anesthetic agents, the half-time
of the blood-brain equilibration is approximately 1
to 3 minutes, accounting for the rate of induction
of anesthesia.
Mechanism of action:
When GABAA receptors are activated, trans membrane chloride
conductance increases, resulting in hyperpolarization of the
postsynaptic cell membrane and functional inhibition of the
postsynaptic neuron.
Indications:
Propofol® is a short-acting intravenous anesthetic
agent suitable for
• Induction and maintenance of general anesthesia.
• Sedation of ventilated patients receiving intensive
care.
• Monitored anesthesia care sedation for surgical
and diagnostic procedures.
Dosage & Administration:
Induction of General Anesthesia
Healthy Adults Less Than 55 Years of Age:
40 mg every 10 seconds until induction onset (2-2.5 mg/kg).
Elderly, Debilitated, or ASA III/IV Patients:
20 mg every 10 seconds until induction onset (1-1.5 mg/kg).
Cardiac Anesthesia:
20 mg every 10 seconds until induction onset (0.5-1.5 mg/kg).
Neurosurgical Patients:
20 mg every 10 seconds until induction onset (1-2 mg/kg).
Pediatric Patients - healthy, from 3-16 years of age:
2.5-3.5 mg/kg administered over 20-30 seconds.
Maintenance of General
Anesthesia
Healthy Adults Less Than 55 Years of Age:
100-200 μg/kg/min (6-12 mg/kg/h).
Elderly, Debilitated, ASA III/IV Patients:
50-100 μg/kg/min (3-6 mg/kg/h).
Pediatric Patients - healthy, 3 years to 16 years of age: 125-
300 μg/kg/min (7.5-18 mg/kg/h)
Cardiac Anesthesia, Most Patients Require:
Primary propofol injectable emulsion with secondary opioid:
100-150 μg/kg/min. Low-dose propofol injectable emulsion
with primary opioid: 50-100 μg/kg/min.
Neurosurgical Patients: 100-200 μg/kg/min (6-12 mg/kg/h).
Contraindication:
• Absolute contraindications: Patients with a known
hypersensitivity to propofol or any of its components;
allergies to eggs, egg products, soybeans or soy
products; disorders of fat metabolism.
• Relative contraindications: Patients undergoing
stereotactic neurosurgery such as pallidotomy, as it
temporary abolishes tremors in patients with
Parkinsonism; Known case of Epilepsy; Untreated
hypertensive, compromised Left ventricle function;
Hepatic or Renal impairment; Pregnant and lactating
mother; Paediatric patients age < 3 years.
Advantages of propofol:
1. Rapid & smooth Recovery.
2. Completed eliminated from body in 4 hours so
patient is ambulatory early.
3. Anti-Emetic.
4. Anti-Pruritic.
5. Bronchodilator.
Competitors:
Brand Name Contains
Dosage
Form
Manufactur
er
Price(Tk.)
FRESOFOL
Propofol
10mg/ml
Injection
Fresenius
Kabi/Hye
Impex
20ml amp x
5s pack:
1758.00
MRP; 50ml
bot x 1s
pack: 779.00
MRP
POFOL I.V
Propofol
10mg/ml
i.v Injection
Popular
Pharmaceut
icals Ltd.
20ml amp x
1s pack:
200.00 MRP
RECOFOL
Propofol
10mg/ml
Injection
Bayer
Schering
Oy/ Tajarat
20ml amp x
1s pack:
MRP; 50ml
vial x 1s
pack:
Thank you
1 sur 14

Recommandé

Propofol - pharmacology, MOA USES, SIDE EFFECTS par
Propofol - pharmacology, MOA USES, SIDE EFFECTSPropofol - pharmacology, MOA USES, SIDE EFFECTS
Propofol - pharmacology, MOA USES, SIDE EFFECTSDR ZIKRULLAH MALLICK
1.5K vues50 diapositives
Propofol par
PropofolPropofol
Propofolasharab tadavi
9.8K vues16 diapositives
Remifentanil par
RemifentanilRemifentanil
RemifentanilGeetanjali Verma
3.9K vues13 diapositives
Induction Agents - Propofol, Sodium Thiopental, Ketamine, par
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Mr.Harshad Khade
2.7K vues29 diapositives
Dexmedetomidine par
DexmedetomidineDexmedetomidine
DexmedetomidineDR ZIKRULLAH MALLICK
884 vues30 diapositives
Fentanyl par
FentanylFentanyl
FentanylDrVishal Kandhway
3.1K vues37 diapositives

Contenu connexe

Tendances

Dexmedetomidine A novel anesthetic agent par
Dexmedetomidine A novel anesthetic agentDexmedetomidine A novel anesthetic agent
Dexmedetomidine A novel anesthetic agentSunder Chapagain
10K vues36 diapositives
Etomidate ketamine par
Etomidate ketamineEtomidate ketamine
Etomidate ketamineHarith Daggupati
3.3K vues46 diapositives
Thiopentone upendra par
Thiopentone upendraThiopentone upendra
Thiopentone upendradr anurag giri
17.6K vues47 diapositives
Skeletal muscle relaxants par
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxantsSimba Syed
6.4K vues16 diapositives
Midazolam in er 1 par
Midazolam in er 1Midazolam in er 1
Midazolam in er 1MEEQAT HOSPITAL
15.3K vues16 diapositives
Iv anaesthetics par
Iv anaestheticsIv anaesthetics
Iv anaestheticsAntara Banerji
14.7K vues26 diapositives

Tendances(20)

Skeletal muscle relaxants par Simba Syed
Skeletal muscle relaxantsSkeletal muscle relaxants
Skeletal muscle relaxants
Simba Syed6.4K vues
ANAESTHESIA-INTRAVENOUS par shrinathraman
ANAESTHESIA-INTRAVENOUSANAESTHESIA-INTRAVENOUS
ANAESTHESIA-INTRAVENOUS
shrinathraman37.3K vues
intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole... par Dr Ravi Shankar Sharma
 intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole... intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole...
intravenous anaesthetic agents incudes benzodiazipenes, opiods,TIVA ,neurole...
Atracurium Vecuronium Pancuronium par Ranjith Thampi
Atracurium Vecuronium PancuroniumAtracurium Vecuronium Pancuronium
Atracurium Vecuronium Pancuronium
Ranjith Thampi10.3K vues
Magnesium and anaesthesia par drmg1976
Magnesium and anaesthesiaMagnesium and anaesthesia
Magnesium and anaesthesia
drmg19761.8K vues

En vedette

Propofol par
PropofolPropofol
Propofolhgvilla
13K vues13 diapositives
Propofol par
PropofolPropofol
PropofolWilder Sandiga Huaman
8.9K vues8 diapositives
Flavie Waters Presentation - SRF Webinar Sep 13, 2012 par
Flavie Waters Presentation - SRF Webinar Sep 13, 2012Flavie Waters Presentation - SRF Webinar Sep 13, 2012
Flavie Waters Presentation - SRF Webinar Sep 13, 2012wef
2.1K vues12 diapositives
Method Development and Validation on Etomidate injection by RP-HPLC par
Method Development and Validation on Etomidate injection by RP-HPLCMethod Development and Validation on Etomidate injection by RP-HPLC
Method Development and Validation on Etomidate injection by RP-HPLCpharmaindexing
445 vues6 diapositives
De Anaya - Diprivan par
De Anaya - DiprivanDe Anaya - Diprivan
De Anaya - Diprivanbinbear4
322 vues14 diapositives
All posters par
All postersAll posters
All postersSahebjit Bhasin
210 vues4 diapositives

En vedette(20)

Propofol par hgvilla
PropofolPropofol
Propofol
hgvilla13K vues
Flavie Waters Presentation - SRF Webinar Sep 13, 2012 par wef
Flavie Waters Presentation - SRF Webinar Sep 13, 2012Flavie Waters Presentation - SRF Webinar Sep 13, 2012
Flavie Waters Presentation - SRF Webinar Sep 13, 2012
wef2.1K vues
Method Development and Validation on Etomidate injection by RP-HPLC par pharmaindexing
Method Development and Validation on Etomidate injection by RP-HPLCMethod Development and Validation on Etomidate injection by RP-HPLC
Method Development and Validation on Etomidate injection by RP-HPLC
pharmaindexing445 vues
De Anaya - Diprivan par binbear4
De Anaya - DiprivanDe Anaya - Diprivan
De Anaya - Diprivan
binbear4322 vues
Judith Ford Presentation - SRF Webinar Sep 13, 2012 par wef
Judith Ford Presentation - SRF Webinar Sep 13, 2012Judith Ford Presentation - SRF Webinar Sep 13, 2012
Judith Ford Presentation - SRF Webinar Sep 13, 2012
wef3.1K vues
Monitored anaesthesia care par AnaestHSNZ
Monitored anaesthesia careMonitored anaesthesia care
Monitored anaesthesia care
AnaestHSNZ23.9K vues
COMCURE: Brochure Areas de Proteccion par COMCURE
COMCURE: Brochure Areas de ProteccionCOMCURE: Brochure Areas de Proteccion
COMCURE: Brochure Areas de Proteccion
COMCURE214 vues
Bmc hist unit 2_authoritarian_regimes_hitler'spolicies_slideshare par Adrian Peeris
Bmc hist unit 2_authoritarian_regimes_hitler'spolicies_slideshareBmc hist unit 2_authoritarian_regimes_hitler'spolicies_slideshare
Bmc hist unit 2_authoritarian_regimes_hitler'spolicies_slideshare
Adrian Peeris561 vues
Slideshare net d_csoport par medley79
Slideshare net d_csoportSlideshare net d_csoport
Slideshare net d_csoport
medley79324 vues

Similaire à Propofol (techno drugs ltd)

Ped medhandbook par
Ped medhandbookPed medhandbook
Ped medhandbookElhadi Hajow
3.4K vues27 diapositives
Ped medhandbook par
Ped medhandbookPed medhandbook
Ped medhandbookElhadi Hajow
2.8K vues27 diapositives
Pediatric intubation pharmacology par
Pediatric intubation pharmacology Pediatric intubation pharmacology
Pediatric intubation pharmacology tfalgiani
1.2K vues15 diapositives
Premedicant drugs in Anesthesia par
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaVaishali Syal
11.8K vues50 diapositives
Propofol anesthetics par
Propofol anestheticsPropofol anesthetics
Propofol anestheticsWarson Monsang
59 vues14 diapositives

Similaire à Propofol (techno drugs ltd)(20)

Pediatric intubation pharmacology par tfalgiani
Pediatric intubation pharmacology Pediatric intubation pharmacology
Pediatric intubation pharmacology
tfalgiani1.2K vues
Premedicant drugs in Anesthesia par Vaishali Syal
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in Anesthesia
Vaishali Syal11.8K vues
Pre anesthetic medications by Meghana C par MEGHANA C
Pre anesthetic medications by Meghana CPre anesthetic medications by Meghana C
Pre anesthetic medications by Meghana C
MEGHANA C618 vues
Solace Biotech Product Start With Letter "O" par Kamal Chawla
Solace Biotech Product Start With Letter "O"Solace Biotech Product Start With Letter "O"
Solace Biotech Product Start With Letter "O"
Kamal Chawla581 vues
Atropine Sulfate par JEllou RAy
Atropine SulfateAtropine Sulfate
Atropine Sulfate
JEllou RAy4.1K vues
Pediatric pain protocol Al Razi Anesthesia department Kuwait par Farah Jafri
Pediatric pain protocol Al Razi Anesthesia department KuwaitPediatric pain protocol Al Razi Anesthesia department Kuwait
Pediatric pain protocol Al Razi Anesthesia department Kuwait
Farah Jafri1.5K vues

Plus de Faruk Hossain

Diabetes Mellitus & Wedica par
Diabetes Mellitus & WedicaDiabetes Mellitus & Wedica
Diabetes Mellitus & WedicaFaruk Hossain
479 vues30 diapositives
Doing business in Russia: a cultural context par
Doing business in Russia: a cultural contextDoing business in Russia: a cultural context
Doing business in Russia: a cultural contextFaruk Hossain
145 vues10 diapositives
Bangladesh Pharmaceutical Market & It's Future (for non pharma background) par
Bangladesh Pharmaceutical Market & It's Future (for non pharma background)Bangladesh Pharmaceutical Market & It's Future (for non pharma background)
Bangladesh Pharmaceutical Market & It's Future (for non pharma background)Faruk Hossain
2.3K vues22 diapositives
Wedica (Trelagliptin) par
Wedica (Trelagliptin) Wedica (Trelagliptin)
Wedica (Trelagliptin) Faruk Hossain
1.1K vues13 diapositives
Chemotherapy Protocol of NSCLC par
Chemotherapy Protocol of NSCLCChemotherapy Protocol of NSCLC
Chemotherapy Protocol of NSCLCFaruk Hossain
498 vues26 diapositives
Treatment options for lung cancer par
Treatment options for lung cancerTreatment options for lung cancer
Treatment options for lung cancerFaruk Hossain
2.3K vues31 diapositives

Plus de Faruk Hossain(13)

Doing business in Russia: a cultural context par Faruk Hossain
Doing business in Russia: a cultural contextDoing business in Russia: a cultural context
Doing business in Russia: a cultural context
Faruk Hossain145 vues
Bangladesh Pharmaceutical Market & It's Future (for non pharma background) par Faruk Hossain
Bangladesh Pharmaceutical Market & It's Future (for non pharma background)Bangladesh Pharmaceutical Market & It's Future (for non pharma background)
Bangladesh Pharmaceutical Market & It's Future (for non pharma background)
Faruk Hossain2.3K vues
Chemotherapy Protocol of NSCLC par Faruk Hossain
Chemotherapy Protocol of NSCLCChemotherapy Protocol of NSCLC
Chemotherapy Protocol of NSCLC
Faruk Hossain498 vues
Treatment options for lung cancer par Faruk Hossain
Treatment options for lung cancerTreatment options for lung cancer
Treatment options for lung cancer
Faruk Hossain2.3K vues
Treatment options for lung cancer par Faruk Hossain
Treatment options for lung cancerTreatment options for lung cancer
Treatment options for lung cancer
Faruk Hossain125 vues
Ceflenic (Cefuroxime + Clavulanic Acid by Techno Drugs Ltd.) par Faruk Hossain
Ceflenic (Cefuroxime + Clavulanic Acid by Techno Drugs Ltd.)Ceflenic (Cefuroxime + Clavulanic Acid by Techno Drugs Ltd.)
Ceflenic (Cefuroxime + Clavulanic Acid by Techno Drugs Ltd.)
Faruk Hossain3.7K vues
Nano emulsion propofol (Techno Drugs Ltd) par Faruk Hossain
Nano emulsion propofol (Techno Drugs Ltd)Nano emulsion propofol (Techno Drugs Ltd)
Nano emulsion propofol (Techno Drugs Ltd)
Faruk Hossain1.1K vues
Cynocort (Triamcinolone Acetonide BP) par Faruk Hossain
Cynocort (Triamcinolone Acetonide BP)Cynocort (Triamcinolone Acetonide BP)
Cynocort (Triamcinolone Acetonide BP)
Faruk Hossain1.2K vues
Presentation cell tissue and organ par Faruk Hossain
Presentation cell tissue and organPresentation cell tissue and organ
Presentation cell tissue and organ
Faruk Hossain12.7K vues

Dernier

Buccoadhesive drug delivery System.pptx par
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptxABG
178 vues43 diapositives
Testicular tumors.pptx par
Testicular tumors.pptxTesticular tumors.pptx
Testicular tumors.pptxUtkarsh Singhal
38 vues64 diapositives
wound debriderment.pptx par
wound debriderment.pptxwound debriderment.pptx
wound debriderment.pptxKhadijah Nordin
12 vues20 diapositives
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ... par
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...DataNB
19 vues24 diapositives
CCSN Webinar - EAOCRC FINAL [Autosaved].pptx par
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCCSN Webinar - EAOCRC FINAL [Autosaved].pptx
CCSN Webinar - EAOCRC FINAL [Autosaved].pptxCanadian Cancer Survivor Network
17 vues36 diapositives
Calcutta Clinical Course - Allen College of Homoeopathy par
Calcutta Clinical Course - Allen College of HomoeopathyCalcutta Clinical Course - Allen College of Homoeopathy
Calcutta Clinical Course - Allen College of HomoeopathyAllen College
108 vues32 diapositives

Dernier(20)

Buccoadhesive drug delivery System.pptx par ABG
Buccoadhesive drug delivery System.pptxBuccoadhesive drug delivery System.pptx
Buccoadhesive drug delivery System.pptx
ABG178 vues
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ... par DataNB
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...
Impact of Public Health Postnatal Home Visiting in NB on Breastfeeding among ...
DataNB19 vues
Calcutta Clinical Course - Allen College of Homoeopathy par Allen College
Calcutta Clinical Course - Allen College of HomoeopathyCalcutta Clinical Course - Allen College of Homoeopathy
Calcutta Clinical Course - Allen College of Homoeopathy
Allen College108 vues
say no to pressure injury(pathophysiology, prevention, management) par Khadijah Nordin
say no to pressure injury(pathophysiology, prevention, management)say no to pressure injury(pathophysiology, prevention, management)
say no to pressure injury(pathophysiology, prevention, management)
Khadijah Nordin24 vues
George MacGinnis - Future of Ageing 2023 par ILCUK
George MacGinnis - Future of Ageing 2023George MacGinnis - Future of Ageing 2023
George MacGinnis - Future of Ageing 2023
ILCUK36 vues
Ros Wilson - Future of Ageing 2023 par ILCUK
Ros Wilson - Future of Ageing 2023Ros Wilson - Future of Ageing 2023
Ros Wilson - Future of Ageing 2023
ILCUK41 vues
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx par ABG
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptxICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ICH AND WHO GUIDELINES FOR VALIDATION OF EQUIPMENTS.pptx
ABG77 vues

Propofol (techno drugs ltd)

  • 1. Techno Drugs Ltd. Welcome to the training program
  • 2. Short –acting IV anesthetic agent. Propofol Propofol BP
  • 3. Product Profile: • Brand Name: Propofol • Generic Name: Propofol • Therapeutic Class : Anesthesia • Strength : 20 ml IV injection (10 mg/ml )
  • 4. Description: • Propofol® Injectable Emulsion is a sterile, non pyrogenic emulsion containing 10 mg/ml of propofol suitable for intravenous administration. Propofol is slightly soluble in water and, thus, is formulated in a white to light yellow, oil-in-water emulsion. In addition to the active component, Propofol®, the formulation also contains soybean oil (100 mg/ml), glycerol (22.5 mg/ml), egg lecithin (12 mg/ml) and disodium edetate (0.005%) with sodium hydroxide to adjust pH.
  • 5. Pharmacology: Propofol® Injectable Emulsion is an IV sedative- hypnotic agent for use in the induction and maintenance of anesthesia or sedation. IV injection of a therapeutic dose of propofol induces hypnosis, with minimal excitation, usually within 40 seconds from the start of injection (the time for one arm-brain circulation). As with other rapidly acting IV anesthetic agents, the half-time of the blood-brain equilibration is approximately 1 to 3 minutes, accounting for the rate of induction of anesthesia.
  • 7. When GABAA receptors are activated, trans membrane chloride conductance increases, resulting in hyperpolarization of the postsynaptic cell membrane and functional inhibition of the postsynaptic neuron.
  • 8. Indications: Propofol® is a short-acting intravenous anesthetic agent suitable for • Induction and maintenance of general anesthesia. • Sedation of ventilated patients receiving intensive care. • Monitored anesthesia care sedation for surgical and diagnostic procedures.
  • 9. Dosage & Administration: Induction of General Anesthesia Healthy Adults Less Than 55 Years of Age: 40 mg every 10 seconds until induction onset (2-2.5 mg/kg). Elderly, Debilitated, or ASA III/IV Patients: 20 mg every 10 seconds until induction onset (1-1.5 mg/kg). Cardiac Anesthesia: 20 mg every 10 seconds until induction onset (0.5-1.5 mg/kg). Neurosurgical Patients: 20 mg every 10 seconds until induction onset (1-2 mg/kg). Pediatric Patients - healthy, from 3-16 years of age: 2.5-3.5 mg/kg administered over 20-30 seconds.
  • 10. Maintenance of General Anesthesia Healthy Adults Less Than 55 Years of Age: 100-200 μg/kg/min (6-12 mg/kg/h). Elderly, Debilitated, ASA III/IV Patients: 50-100 μg/kg/min (3-6 mg/kg/h). Pediatric Patients - healthy, 3 years to 16 years of age: 125- 300 μg/kg/min (7.5-18 mg/kg/h) Cardiac Anesthesia, Most Patients Require: Primary propofol injectable emulsion with secondary opioid: 100-150 μg/kg/min. Low-dose propofol injectable emulsion with primary opioid: 50-100 μg/kg/min. Neurosurgical Patients: 100-200 μg/kg/min (6-12 mg/kg/h).
  • 11. Contraindication: • Absolute contraindications: Patients with a known hypersensitivity to propofol or any of its components; allergies to eggs, egg products, soybeans or soy products; disorders of fat metabolism. • Relative contraindications: Patients undergoing stereotactic neurosurgery such as pallidotomy, as it temporary abolishes tremors in patients with Parkinsonism; Known case of Epilepsy; Untreated hypertensive, compromised Left ventricle function; Hepatic or Renal impairment; Pregnant and lactating mother; Paediatric patients age < 3 years.
  • 12. Advantages of propofol: 1. Rapid & smooth Recovery. 2. Completed eliminated from body in 4 hours so patient is ambulatory early. 3. Anti-Emetic. 4. Anti-Pruritic. 5. Bronchodilator.
  • 13. Competitors: Brand Name Contains Dosage Form Manufactur er Price(Tk.) FRESOFOL Propofol 10mg/ml Injection Fresenius Kabi/Hye Impex 20ml amp x 5s pack: 1758.00 MRP; 50ml bot x 1s pack: 779.00 MRP POFOL I.V Propofol 10mg/ml i.v Injection Popular Pharmaceut icals Ltd. 20ml amp x 1s pack: 200.00 MRP RECOFOL Propofol 10mg/ml Injection Bayer Schering Oy/ Tajarat 20ml amp x 1s pack: MRP; 50ml vial x 1s pack: